Unveiling pharmacological targets of Rihimaside C for radiation-induced lung injury: An in silico and experimental integrated approach

Unveiling pharmacological targets of Rihimaside C for radiation-induced lung injury: An in silico and experimental integrated approach

Background and aim: Radiation-induced lung injury (RILI) is a common complication during caner radiotherapy, mainly characterized by oxidative stress and inflammation. Rihimaside C, a novel dihydroflavonol compound isolated from Ribes himalense, exhibits significant anti-inflammatory and antioxidant...

Full description

Saved in:
Bibliographic Details
Main Authors: Youyi Liu, Jingrou Guo, Chuang Liu, Xingyi Chen, Yifei Tang, Minchen Wu, Jianfeng Huang
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Journal of Traditional and Complementary Medicine
Subjects:
Radiation-induced lung injury
Rihimaside C
Ribes himalense
Network pharmacology
HSP90
Online Access:http://www.sciencedirect.com/science/article/pii/S2225411024000658
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items